Clinical Trial Update: Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 study evaluating pembrolizumab in patients with advanced solid tumors, including squamous cell carcinoma of the head and neck, triple-negative breast ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Malignant Melanoma
• Squamous Cell Carcinoma of the Head and Neck
• Triple-negative Breast Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Squamous Cell Cancer of Head and Neck, Triple Negative Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING